questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 December 2023 to Question 7053 on Elexacaftor/tezacaftor/ivacaftor, what her Department's expected timetable is for when NICE will publish its final guidance on the use of ivacaftor–tezacaftor–elexacaftor for treating cystic fibrosis.
answerText: The Government wants National Health Service patients to benefit from effective treatments, in a way that represents value, and is fair to all parties. The National Institute of Health and Care Excellence (NICE) makes recommendations on whether medicines ...
heading: Ivacaftor/tezacaftor/elexacaftor